K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENT1 dose, once a month.Defends dogs against ticks and fleas and also protects against heartworm disease, roundworms, hookworms and tapeworms. + Learn More